Metformin improves endothelial function and carotid intima media thickness in patients with PCOS

Gynecological Endocrinology

Volumn 31, Issue 5, 2015, Pages 401-405

  Kaya, Mehmet Gungor ^a   Yildirim, Sumeyra ^a   Calapkorur, Bekir ^a   Akpek, Mahmut ^a   Unluhizarci, Kursad ^a   Kelestimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Carotid intima media thickness; Flow mediated vasodilatation; Metformin; Oral contraceptive pills; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ESTRADIOL; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; METFORMIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL; ANDROSTANE DERIVATIVE; ANTIDIABETIC AGENT; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; ARTERY DILATATION; ARTICLE; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEDIATED VASODILATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LABORATORY TEST; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WEIGHT REDUCTION; YOUNG ADULT; CAROTID ARTERY; DRUG COMBINATION; ECHOGRAPHY; TREATMENT OUTCOME; VASODILATATION;

ADOLESCENT; ADULT; ANDROSTENES; BRACHIAL ARTERY; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CONTRACEPTIVES, ORAL, COMBINED; DRUG THERAPY, COMBINATION; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME; TREATMENT OUTCOME; VASODILATION; YOUNG ADULT;

EID: 84931313964     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1006188     Document Type: Article

References (24)

1. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertil Steril 2002;77:1095-105.
2. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;370:685-97.
3. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2694-8.
4. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352: 1223-36.
5. Dogan A, Yarlioglues M, Kaya MG, et al. Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients. Blood Press 2011;20:182-7.
6. Yurdakul S, Erdemir VA, Yldrmtürk O, et al. Evaluation of endothelial functions in patients with Behcet's disease without overt vascular involvement. Turk Kardiyol Dern Ars 2012;40:518-22.
7. Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009;91:456-88.
8. Professional Practice Committee, American Diabetes Association. Clinical practice recommendations. Diabetes Care 2004;27:S5-10.
9. Sahin Y, Unluhizarci K, Yilmazsoy A, et al. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007;67:904-8.
10. Cascella T, Palomba S, Tauchmanovà L, et al. Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2006;91:4395-400.
11. Inanc MT, Kalay N, Heyit T, et al. Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease. Echocardiography 2010;27:997-1003.
12. Kaya MG, Gunebakmaz O, Zencir C, et al. Assessment of elastic properties of aorta in non-obese polycystic ovarian syndrome. Fertil Steril 2010;94:2402-5.
13. Arnal JF, Fontaine C, Billon-Galés A, et al. Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol 2010;30:1506-12.
14. Nader S, Diamanti-Kandarakis E. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod 2007;22:317-322.
15. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995;91:1314-9.
16. Crouse III JR, Craven TE, Hagaman AP, Bond MG. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation 1995;92:1141-7.
17. Agarwal N, Rice SP, Bolusani H, et al. Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab 2010;95:722-30.
18. Carmina E, Orio F, Palomba S, et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 2006;119: 356.
19. Unlühizarci K, Kelęstimur F, Bayram F, et al. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1999;51:231-6.
20. Orio Jr. F, Palomba S, Cascella T, et al. Improvement in endothelial structure and function after metformin treatment in young normalweight women with polycystic ovary syndrome: results of a 6-month study. J Clin Endocrinol Metab 2005;90:6072-6.
21. Topcu S, Tok D, Caliskan M, et al. Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance. Clin Endocrinol 2006;65:75-80.
22. Le, TN, Nestler, JE, Strauss III JF, Wickham III EP. Sex hormonebinding globulin and type 2 diabetes mellitus. Trends Endocrinol Metabolism 2012;23:32-40.
23. Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the poly-cystic ovary syndrome. J Clin Endocrinol Metab 2000;85:2767-74.
24. Kaya MG, Calapkorur B, Karaca Z, et al. The effects of treatment with drospirenone/ethinyl estradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012;77:885-92.